NT-814: Neurokinin Receptor Antagonist Effective for Menopausal Vasomotor Symptoms
Stimulation of NKB-neurokinin 3 receptor (NK3R) signalling can induce hot flashes
Stimulation of NKB-neurokinin 3 receptor (NK3R) signalling can induce hot flashes
In 2008, the National Institutes of Health funded the Menopause Strategies: Finding Lasting Answers for Symptoms and Health or MSFlash clinical trials network. The primary goal of MSFlash has been to find and test [...]
While earlier observational studies suggested that hormone treatment may improve cognitive functioning in peri- and postmenopausal women, studies from the Women’s Health Initiative (WHI) demonstrated that estrogen replacement therapy started in postmenopausal women (65 [...]
About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase. For most, the symptoms are manageable, but for a sizeable subset of midlife [...]
Up to 80% of women experience symptoms as they transition into the menopause, including vasomotor symptoms, sleep disturbance, and depressive symptoms. While hormone replacement therapy and certain medications may be helpful, these interventions may have [...]
Increasing numbers of peri- and post-menopausal women request “bioidentical” rather than synthetic hormones. Although there is a tendency to think of bioidentical hormones as “all-natural”, they, like synthetic hormones, are manufactured in the laboratory. In [...]
Previous studies have shown that women with poor physical health are more likely to suffer from depression during the perimenopause and menopause. A new study demonstrates that in healthy women, there is also a correlation [...]
Peri- and post-menopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes; however, a study from researchers at Wayne State University School of Medicine suggests that [...]
About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase. For most, the symptoms are manageable, but for a sizeable subset of midlife [...]
Hypoactive sexual desire disorder (HSDD) is the most common type of female sexual dysfunction, affecting approximately 10% of all adult women. In certain populations of women that we see in our clinic, including women [...]